A
20.72
0.48 (2.37%)
| Previous Close | 20.24 |
| Open | 20.41 |
| Volume | 2,125,502 |
| Avg. Volume (3M) | 2,238,956 |
| Market Cap | 3,077,959,936 |
| Price / Earnings (Forward) | 140.85 |
| Price / Sales | 4.59 |
| Price / Book | 291.14 |
| 52 Weeks Range | |
| Earnings Date | 30 Oct 2025 |
| Profit Margin | -25.77% |
| Operating Margin (TTM) | -18.74% |
| Diluted EPS (TTM) | -1.14 |
| Quarterly Revenue Growth (YOY) | 22.20% |
| Total Debt/Equity (MRQ) | 6,465.30% |
| Current Ratio (MRQ) | 2.76 |
| Operating Cash Flow (TTM) | -11.25 M |
| Levered Free Cash Flow (TTM) | -24.32 M |
| Return on Assets (TTM) | -9.33% |
| Return on Equity (TTM) | -291.71% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | Alphatec Holdings, Inc. | Bullish | Bullish |
AIStockmoo Score
-0.3
| Analyst Consensus | 1.5 |
| Insider Activity | -4.0 |
| Price Volatility | -3.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 4.0 |
| Average | -0.30 |
|
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Core |
| % Held by Insiders | 21.42% |
| % Held by Institutions | 63.24% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 25.00 (Piper Sandler, 20.66%) | Buy |
| 25.00 (Canaccord Genuity, 20.66%) | Buy | |
| Median | 23.00 (11.00%) | |
| Low | 16.00 (Wells Fargo, -22.78%) | Buy |
| Average | 22.11 (6.71%) | |
| Total | 8 Buy, 1 Hold | |
| Avg. Price @ Call | 18.32 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Morgan Stanley | 10 Nov 2025 | 21.00 (1.35%) | Hold | 20.24 |
| Barclays | 03 Nov 2025 | 23.00 (11.00%) | Buy | 19.29 |
| Canaccord Genuity | 31 Oct 2025 | 25.00 (20.66%) | Buy | 18.99 |
| HC Wainwright & Co. | 31 Oct 2025 | 24.00 (15.83%) | Buy | 18.99 |
| Needham | 31 Oct 2025 | 22.00 (6.18%) | Buy | 18.99 |
| Piper Sandler | 31 Oct 2025 | 25.00 (20.66%) | Buy | 18.99 |
| Stifel | 31 Oct 2025 | 24.00 (15.83%) | Buy | 18.99 |
| 28 Oct 2025 | 20.00 (-3.47%) | Buy | 16.65 | |
| JP Morgan | 24 Oct 2025 | 19.00 (-8.30%) | Buy | 16.11 |
| Wells Fargo | 16 Oct 2025 | 16.00 (-22.78%) | Buy | 14.26 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| LISH SCOTT | - | 19.61 | -25,000 | -490,250 |
| MARSHALL TYSON ELIOT | - | 19.61 | -70,000 | -1,372,700 |
| PELIZZON DAVID R | - | 20.63 | -250,000 | -5,157,500 |
| PRITZKER JENNIFER N. | - | 20.63 | -250,000 | -5,157,500 |
| SQUADRON CAPITAL LLC | - | 20.63 | -250,000 | -5,157,500 |
| SQUADRON CAPITAL HOLDINGS LLC | - | 20.63 | -250,000 | -5,157,500 |
| Aggregate Net Quantity | -1,095,000 | |||
| Aggregate Net Value ($) | -22,492,950 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 20.29 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| SQUADRON CAPITAL LLC | 24 Nov 2025 | Sell (-) | 250,000 | 20.63 | 5,157,500 | |
| PELIZZON DAVID R | Director | 24 Nov 2025 | Sell (-) | 250,000 | 20.63 | 5,157,500 |
| SQUADRON CAPITAL HOLDINGS LLC | 24 Nov 2025 | Sell (-) | 250,000 | 20.63 | 5,157,500 | |
| PRITZKER JENNIFER N. | 24 Nov 2025 | Sell (-) | 250,000 | 20.63 | 5,157,500 | |
| LISH SCOTT | Officer | 20 Nov 2025 | Sell (-) | 25,000 | 19.61 | 490,250 |
| LISH SCOTT | Officer | 20 Nov 2025 | Option execute | 25,000 | - | - |
| MARSHALL TYSON ELIOT | Officer | 20 Nov 2025 | Sell (-) | 70,000 | 19.61 | 1,372,700 |
| Date | Type | Details |
|---|---|---|
| 07 Nov 2025 | Announcement | ATEC Mourns Passing of Board Member Jeffrey P. Rydin |
| 30 Oct 2025 | Announcement | ATEC Reports Third Quarter 2025 Financial Results And Raises Full-Year Guidance |
| 16 Oct 2025 | Announcement | ATEC to Report Third Quarter 2025 Financial Results on October 30, 2025 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |